iScience (Feb 2023)

Myeloid-cell-specific role of Gasdermin D in promoting lung cancer progression in mice

  • C. Alicia Traughber,
  • Gauravi M. Deshpande,
  • Kalash Neupane,
  • Nilam Bhandari,
  • Mariam R. Khan,
  • Megan R. McMullen,
  • Shadi Swaidani,
  • Emmanuel Opoku,
  • Santoshi Muppala,
  • Jonathan D. Smith,
  • Laura E. Nagy,
  • Kailash Gulshan

Journal volume & issue
Vol. 26, no. 2
p. 106076

Abstract

Read online

Summary: The activities of the NLRP3 and AIM2 inflammasomes and Gasdermin D (GsdmD) are implicated in lung cancer pathophysiology but it’s not clear if their contributions promote or retard lung cancer progression. Using a metastatic Lewis lung carcinoma (LLC) cell model, we show that GsdmD knockout (GsdmD−/−) mice form significantly fewer cancer foci in lungs, exhibit markedly decreased lung cancer metastasis, and show a significant ∼50% increase in median survival rate. The cleaved forms of GsdmD and IL-1β were detected in lung tumor tissue, indicating inflammasome activity in lung tumor microenvironment (TME). Increased migration and growth of LLC cells was observed upon exposure to the conditioned media derived from inflammasome-induced wild type, but not the GsdmD−/−, macrophages. Using bone marrow transplantations, we show a myeloid-specific contribution of GsdmD in lung cancer metastasis. Taken together, our data show that GsdmD plays a myeloid-specific role in lung cancer progression.

Keywords